FDA 510(k) Strategy & Intended Use Consulting
Get expert guidance for FDA 510(k) regulatory strategy, predicate selection, and intended use positioning that supports a stronger, more defensible submission. Elexes helps medical device manufacturers align claims, testing, and documentation early so teams can reduce avoidable deficiencies, protect timelines, and move toward FDA clearance with greater confidence.
Our FDA 510(k) Services
Strategic consulting services that strengthen 510(k) planning, documentation, and FDA submission readiness.
510(k) Strategy
Develop a tailored FDA 510(k) pathway that defines submission type, review approach, special controls, and likely FDA focus areas to support efficient, commercially meaningful clearance planning.
Predicate Strategy
Identify and evaluate legally marketed predicates by intended use, technological characteristics, and classification to build a substantial equivalence position that is defensible and strategically sound.
Intended Use Alignment
Craft precise intended use and indications for use statements that support predicate comparison, align with labeling, and help avoid overbroad or unsupported claims in the submission.
Submission Readiness
Assess device documentation, testing, risk files, and quality system elements against FDA expectations before submission to uncover gaps early and reduce preventable review delays.
Pre-Sub Support
Prepare strategic Q-Sub and pre-submission packages, refine key FDA questions, and support mock meetings so your team enters agency interactions with clarity and confidence.
FDA Deficiency Response
Respond to Additional Information requests and other FDA questions with structured, evidence-based answers that directly address reviewer concerns and support faster resolution.
Strategic Submission Support
Build a Stronger 510(k) Submission
FDA 510(k) success depends on more than assembling documents. Elexes helps manufacturers define the right regulatory pathway, sharpen intended use language, select defensible predicates, and align testing, labeling, and risk documentation into one coherent submission story. The result is a clearer strategy, fewer avoidable deficiencies, and a submission package built to withstand FDA scrutiny while supporting practical commercial claims after clearance.
Trusted By Manufacturers
Success Stories
See how manufacturers rely on Elexes for clearer strategy, stronger submissions, and confident regulatory execution.
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
The Elexes Difference
Why Choose Elexes?
Manufacturers choose Elexes for disciplined regulatory strategy backed by broad medical device expertise.
Deep Experience
50+ years of collective experience across FDA, ISO, and global medical device frameworks.
End-to-End Support
From strategy through post-market support, Elexes helps keep submissions aligned and execution consistent.
Submission Focus
250+ successful projects and 200+ product types inform practical, review-ready 510(k) planning.
Flexible Engagement
Project-based, part-time, or embedded support gives teams expert help without adding headcount.
Meet The Elexes Team
Experienced specialists guiding complex regulatory decisions.
Elexes is a trusted medical device regulatory consulting partner supporting manufacturers through complex approval and compliance demands. The team brings 50+ years of collective experience across FDA submissions, quality systems, clinical documentation, and global market access strategy. Over time, Elexes has become a go-to resource for companies that need practical regulatory judgment, disciplined documentation support, and end-to-end project management from development through post-market obligations. With experience spanning 200+ product types and 250+ successful projects, the company helps clients reduce avoidable submission risk, strengthen technical files, and move forward with clearer regulatory direction. Its approach combines strategic insight, measurable execution, and confidentiality for manufacturers operating in highly scrutinized environments.
200+ Product TypesExperience spanning diverse medical device categories and technologies.90% Audits ClearedStrong track record supporting inspection and audit readiness.250+ Successful ProjectsDelivered across a wide range of regulatory and compliance engagements.
Frequently Asked Questions
What is 510k intended use?
In an FDA 510(k), intended use describes the general purpose of the device, including what it does, who it is for, and the clinical setting or condition it addresses. It is central to substantial equivalence because FDA compares your intended use to the predicate device. If the wording is too broad, inconsistent, or unsupported by evidence, it can trigger major review questions or derail the submission.
What are the FDA 510k rules?
FDA 510(k) rules require a manufacturer to show that a device is substantially equivalent to a legally marketed predicate device. The submission must include device description, intended use, indications for use, comparison to the predicate, performance testing, labeling, and other applicable technical sections. FDA also expects the submission format, evidence quality, and claims to align with current guidance and device-specific requirements.
Why is intended use so important in a 510(k)?
Intended use is one of the first things FDA evaluates because it shapes predicate selection, testing strategy, labeling, and the substantial equivalence argument. If your intended use differs materially from the predicate, FDA may determine the device is not appropriate for the 510(k) pathway. Clear, precise language helps support review efficiency and reduces the risk of avoidable Additional Information requests.
How do you choose the right predicate device?
A strong predicate is selected by analyzing intended use, indications, technological characteristics, classification regulation, product code, and performance expectations. The goal is not simply to find a similar device, but to identify one that supports a credible substantial equivalence argument. A poor predicate choice can create unnecessary comparison weaknesses, increase reviewer concerns, and complicate the entire submission strategy.
When should a company start 510(k) strategy work?
510(k) strategy should begin well before submission drafting, ideally during development planning or design verification planning. Early strategy work helps define the likely pathway, predicate approach, testing needs, labeling boundaries, and documentation gaps before they become expensive delays. Starting early also improves coordination across regulatory, engineering, clinical, and quality teams so the submission package is built intentionally rather than assembled reactively.
Do all 510(k) submissions need clinical data?
No, many 510(k) submissions rely on bench, software, biocompatibility, sterility, EMC, or other non-clinical testing to support substantial equivalence. However, some devices do require clinical evidence depending on their technology, claims, risk profile, or the limitations of available predicates. A proper regulatory strategy evaluates this early so the evidence plan is proportionate, scientifically justified, and aligned with FDA expectations.
What happens if FDA sends an Additional Information request?
An Additional Information request means FDA needs clarification, missing evidence, or stronger justification before continuing review. The response should address each deficiency directly, using organized technical rationale, updated documents, and complete supporting data where needed. A weak or incomplete response can lead to further delays, another round of questions, or submission withdrawal, so structured response planning is critical.
What should be reviewed before submitting a 510(k)?
Before submission, manufacturers should review intended use and indications, predicate rationale, device description, labeling consistency, risk management documentation, test reports, software records if applicable, and overall traceability across the package. A readiness assessment should also confirm that the submission aligns with current FDA guidance and eSTAR expectations. This pre-submission review helps identify gaps before they become formal deficiencies.
Still Have 510(k) Questions?
Talk with regulatory experts about your submission strategy and intended use.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality system expertise.
MDSAP
Supports multi-market quality compliance.
IEC 62304
Software lifecycle compliance knowledge.
